Form D · Private Equity Fund

Drug Royalty III (Feeder DE), L.P.

Wilmington, DE · CIK 0001565607

Offering snapshot reported Sep 16, 2013 · SEC filing

Reported sold
$457M
Indefinite offering
Investors reported
30
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Dec 21, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$229M$457MJan 4, 2013: $13,500,000.00Jan 4, 2013Feb 26, 2013: $173,500,000.00Feb 26, 2013Apr 18, 2013: $339,350,000.00Apr 18, 2013Jun 14, 2013: $378,700,000.00Jun 14, 2013Aug 2, 2013: $424,700,000.00Aug 2, 2013Sep 16, 2013: $457,200,000.00Sep 16, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$424,700,000 → $457,200,000
  • Reported investors29 → 30

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 16, 2013Amendment$457,200,000$32,500,000vs Aug 2, 201330SEC filing
Aug 2, 2013Amendment$424,700,000$46,000,000vs Jun 14, 201329SEC filing
Jun 14, 2013Amendment$378,700,000$39,350,000vs Apr 18, 201320SEC filing
Apr 18, 2013Amendment$339,350,000$165,850,000vs Feb 26, 201315SEC filing
Feb 26, 2013Amendment$173,500,000$160,000,000vs Jan 4, 20136SEC filing
Jan 4, 2013Initial$13,500,000No comparison2SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$4.28M (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-189587
Commission contingent on certain milestones.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Atlantic-Pacific Capital, Inc.38356

Source: Form D, filed Sep 16, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

DRUG ROYALTY III (FEEDER DE), L.P.

Investment adviser: DRI CAPITAL INC.

Gross asset value
$163M
Beneficial owners
30
ADV minimum commitment
$10M

Reported in Form ADV on Jun 22, 2021. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Auditor DELOITTE LLP, CANADA TORONTO, Canada
Custodian WELLS FARGO BANK N.A. SAN FRANCISCO, California, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
No
External marketing
No

DELOITTE LLP, CANADA
PCAOB 1208

WELLS FARGO BANK N.A.
LEI KB1H1DSPRFMYMCUFXT09

Filing source

Form ADV 1541206 · Jun 22, 2021 · Schedule D 7.B.(1), fund 805-7688610891

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ali Hedayat Director
Abali J. Hoilett Director
Behzad Khosrowshahi Director
Ali Seirafi Director
William Shaw Director
M. Craig Shepherd Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Corporation Service Company 2711 Centerville Road, Suite 400
Wilmington, DE, 19808